Cargando…
Upregulation of retinoic acid receptor-β reverses drug resistance in cholangiocarcinoma cells by enhancing susceptibility to apoptosis
Retinoic acid receptor β (RARβ), a known tumor suppressor gene, is frequently silenced in numerous malignant types of tumor. Recent reports have demonstrated that loss of RARβ expression may be responsible, in part, for the drug resistance observed in clinical trials. However, little is known about...
Autores principales: | Ren, Hong-Yue, Chen, Bo, Huang, Gui-Li, Liu, Yu, Shen, Dong-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042735/ https://www.ncbi.nlm.nih.gov/pubmed/27599527 http://dx.doi.org/10.3892/mmr.2016.5701 |
Ejemplares similares
-
Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β‐catenin and nuclear factor‐κB pathways
por: Huang, Gui‐Li, et al.
Publicado: (2015) -
Fenretinide-induced apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid receptor β dependent
por: Bu, Pengli, et al.
Publicado: (2007) -
PTGDR expression is upregulated through retinoic acid receptors (RAR) mechanism in allergy
por: García-Sánchez, Asunción, et al.
Publicado: (2019) -
All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells
por: Butsri, Siriwoot, et al.
Publicado: (2022) -
Overexpression of Retinoic Acid Receptor β Induces Growth Arrest and Apoptosis in Oral Cancer Cell Lines
por: Hayashi, Ken, et al.
Publicado: (2001)